Switch theme
Sign up to access all valuation multiples
Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.
2000
n/a
LTM Revenue $379M
LTM EBITDA $92.1M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Zhejiang Jolly has a last 12-month revenue of $379M and a last 12-month EBITDA of $92.1M.
In the most recent fiscal year, Zhejiang Jolly achieved revenue of $268M and an EBITDA of $71.5M.
Zhejiang Jolly expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Zhejiang Jolly valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $249M | $268M | XXX | XXX | XXX |
| Gross Profit | $143M | $176M | XXX | XXX | XXX |
| Gross Margin | 58% | 66% | XXX | XXX | XXX |
| EBITDA | $54.1M | $71.5M | XXX | XXX | XXX |
| EBITDA Margin | 22% | 27% | XXX | XXX | XXX |
| Net Profit | $24.7M | $37.6M | XXX | XXX | XXX |
| Net Margin | 10% | 14% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Zhejiang Jolly's stock price is CNY 17 (or $2).
Zhejiang Jolly has current market cap of CNY 11.7B (or $1.6B), and EV of CNY 11.3B (or $1.6B).
See Zhejiang Jolly trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $1.6B | XXX | XXX | XXX | XXX | $0.11 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Zhejiang Jolly has market cap of $1.6B and EV of $1.6B.
Zhejiang Jolly's trades at 4.1x LTM EV/Revenue multiple, and 16.9x LTM EBITDA.
Analysts estimate Zhejiang Jolly's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Zhejiang Jolly and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.6B | XXX | XXX | XXX |
| EV/Revenue | 5.8x | XXX | XXX | XXX |
| EV/EBITDA | 21.7x | XXX | XXX | XXX |
| P/E | 30.4x | XXX | XXX | XXX |
| P/E/Growth | 0.6x | XXX | XXX | XXX |
| EV/FCF | 71.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpZhejiang Jolly's NTM/LTM revenue growth is 23%
Zhejiang Jolly's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Zhejiang Jolly's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Zhejiang Jolly's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Zhejiang Jolly and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 50% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 36% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 46% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zhejiang Jolly acquired XXX companies to date.
Last acquisition by Zhejiang Jolly was XXXXXXXX, XXXXX XXXXX XXXXXX . Zhejiang Jolly acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Zhejiang Jolly founded? | Zhejiang Jolly was founded in 2000. |
| Where is Zhejiang Jolly headquartered? | Zhejiang Jolly is headquartered in China. |
| Is Zhejiang Jolly publicy listed? | Yes, Zhejiang Jolly is a public company listed on SHE. |
| What is the stock symbol of Zhejiang Jolly? | Zhejiang Jolly trades under 300181 ticker. |
| When did Zhejiang Jolly go public? | Zhejiang Jolly went public in 2011. |
| Who are competitors of Zhejiang Jolly? | Similar companies to Zhejiang Jolly include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Zhejiang Jolly? | Zhejiang Jolly's current market cap is $1.6B |
| What is the current revenue of Zhejiang Jolly? | Zhejiang Jolly's last 12-month revenue is $379M. |
| What is the current EBITDA of Zhejiang Jolly? | Zhejiang Jolly's last 12-month EBITDA is $92.1M. |
| What is the current EV/Revenue multiple of Zhejiang Jolly? | Current revenue multiple of Zhejiang Jolly is 4.1x. |
| What is the current EV/EBITDA multiple of Zhejiang Jolly? | Current EBITDA multiple of Zhejiang Jolly is 16.9x. |
| What is the current revenue growth of Zhejiang Jolly? | Zhejiang Jolly revenue growth between 2023 and 2024 was 8%. |
| Is Zhejiang Jolly profitable? | Yes, Zhejiang Jolly is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
